Researchers
Đorić, Ilona
Results 21-40 of 49
Issue Date | Title | Author(s) | Type | Мp-cat. |
---|---|---|---|---|
2021 | TSHR mRNA quantification in circulating thyroid cancer cells shows potential in detecting aggressive forms of DTC![]() | Jelena Janković Miljuš ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2021 | Contemporary molecular-biological investigations of papillary thyroid carcinoma prognostic factors and their potential for application in clinical practice![]() | Ilona Đorić ![]() ![]() ![]() ![]() ![]() ![]() | Book parts | Mp. category will be shown later |
2020 | Coexistence of BRAFV600E mutation and EGFR overexpression is highly associated with adverse clinicopathological features of papillary thyroid carcinoma | Paunovic, Ivan; Šelemetjev, Sonja ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2020 | Elevated BANCR expression levels have different effects on papillary thyroid carcinoma progression depending on the presence of the BRAFV600E mutation![]() | Stojanović, Stefana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21aM21a |
2019 | MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression | Rončević, Jelena ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2019 | High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients![]() | Išić Denčić Tijana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2019 | MMP-9 promotor polymorphisms -1562C>T SNP and microsatellite (CA)13–25x tandem repeats associate with increased MMP-9 expression in papillary thyroid carcinoma | Jelena Rončević ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2019 | The prognostic significance of mRNA splice-deletion variant (FAK-Del33), total mRNA FAK and pY397 FAK protein expressions levels in papillary thyroid carcinoma![]() | Sonja Šelemetjev ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2019 | The effect of the BRAFV600E mutation on the level of expression of BANCR in papillary thyroid carcinoma | Stefana Stojanović ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2018 | β-katenin i BRAFV600E kao markeri agresivne forme papilarnog karcinoma štitne žlezde | Išić Denčić, Tijana M. ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2018 | Genetic Markers for Coronary Artery Disease![]() | Veljković, Nevena V. ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2018 | Genski polimorfizam, ekspresija, i enzimska aktivnost matriksne metaloproteinaze-9 kao prognostički markeri papilarnog karcinoma štitaste žlezde![]() | Ilona Đorić ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2018 | Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression | Šelemetjev, Sonja ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2018 | High expression and localization of beta-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients![]() | Išić Denčić, Tijana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2017 | Genski polimorfizam i enzimska aktivnost matriksne metaloproteinaze-9 kao prognostički markeri papilarnog karcinoma štitaste žlezde![]() | Đorić, Ilona Đ. ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2017 | Overexpression of EGF receptor in papillary thyroid carcinoma correlates with high FAK expression and adverse clinicopathological parameters | Šelemetjev, Sonja A. ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2017 | Concomitant high expression of β-catenin and EGFR associate with unfavourable clinical features of papillary thyroid carcinoma![]() | Išić-Denčić, Tijana M. ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2017 | MMP9 (-1562C/T) gene polymorphism associates with increased MMP-9 level and papillary thyroid carcinoma progression | Ilona Đorić ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2016 | Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated with Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma![]() | Šelemetjev, Sonja ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2015 | Expression analysis of caveolin-1 in papillary thyroid carcinoma with relation to clinicopathological parameters and BRAF mutation status![]() | Janković, Jelena ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |